These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31985106)

  • 1. Neuroticism, conscientiousness, and in vivo Alzheimer pathologies measured by amyloid PET and MRI.
    Byun MS; Jung JH; Sohn BK; Yi D; Lee JH; Jeon SY; Lee Y; Jung GJ; Lee JY; Kim YK; Shin SA; Sohn CH; Kang KM; Lee DY;
    Psychiatry Clin Neurosci; 2020 May; 74(5):303-310. PubMed ID: 31985106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.
    Zhang J; Chen H; Wang J; Huang Q; Xu X; Wang W; Xu W; Guan Y; Liu J; Wardlaw JM; Deng Y; Xie F; Li B
    Alzheimers Dement; 2024 Jun; 20(6):3931-3942. PubMed ID: 38648354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
    Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of moderate alcohol intake with in vivo amyloid-beta deposition in human brain: A cross-sectional study.
    Kim JW; Byun MS; Yi D; Lee JH; Ko K; Jeon SY; Sohn BK; Lee JY; Kim YK; Shin SA; Sohn CH; Lee DY;
    PLoS Med; 2020 Feb; 17(2):e1003022. PubMed ID: 32097439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
    Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
    Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of cortical thinning in Alzheimer's disease signature regions associate with vascular burden but not with β-amyloid status in cognitively normal adults at age 70.
    Keuss SE; Coath W; Cash DM; Barnes J; Nicholas JM; Lane CA; Parker TD; Keshavan A; Buchanan SM; Wagen AZ; Storey M; Harris M; Lu K; James SN; Street R; Malone IB; Sudre CH; Thomas DL; Dickson JC; Barkhof F; Murray-Smith H; Wong A; Richards M; Fox NC; Schott JM
    J Neurol Neurosurg Psychiatry; 2024 Jul; 95(8):748-752. PubMed ID: 38199813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
    Provenzano FA; Muraskin J; Tosto G; Narkhede A; Wasserman BT; Griffith EY; Guzman VA; Meier IB; Zimmerman ME; Brickman AM;
    JAMA Neurol; 2013 Apr; 70(4):455-61. PubMed ID: 23420027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.
    Ottoy J; Ozzoude M; Zukotynski K; Adamo S; Scott C; Gaudet V; Ramirez J; Swardfager W; Cogo-Moreira H; Lam B; Bhan A; Mojiri P; Kang MS; Rabin JS; Kiss A; Strother S; Bocti C; Borrie M; Chertkow H; Frayne R; Hsiung R; Laforce RJ; Noseworthy MD; Prato FS; Sahlas DJ; Smith EE; Kuo PH; Sossi V; Thiel A; Soucy JP; Tardif JC; Black SE; Goubran M;
    Alzheimers Dement; 2023 Apr; 19(4):1503-1517. PubMed ID: 36047604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coffee intake and decreased amyloid pathology in human brain.
    Kim JW; Byun MS; Yi D; Lee JH; Jeon SY; Jung G; Lee HN; Sohn BK; Lee JY; Kim YK; Shin SA; Sohn CH; Lee DY;
    Transl Psychiatry; 2019 Oct; 9(1):270. PubMed ID: 31641100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration.
    Busatto Filho G; Duran FLS; Squarzoni P; Coutinho AMN; Rosa PGP; Torralbo L; Pachi CGDF; da Costa NA; Porto FHG; Carvalho CL; Brucki SMD; Nitrini R; Forlenza OV; Leite CDC; Buchpiguel CA; de Paula Faria D
    J Neurosci Res; 2021 Feb; 99(2):481-501. PubMed ID: 33073383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of T
    Boles Ponto LL; Magnotta VA; Menda Y; Moser DJ; Oleson JJ; Harlynn EL; DeVries SD; Wemmie JA; Schultz SK
    J Neuropsychiatry Clin Neurosci; 2020; 32(4):352-361. PubMed ID: 32283991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals.
    d'Oleire Uquillas F; Jacobs HIL; Hanseeuw B; Marshall GA; Properzi M; Schultz AP; LaPoint MR; Johnson KA; Sperling RA; Vannini P
    Neuroimage Clin; 2018; 17():388-396. PubMed ID: 29159051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of white matter hyperintensities and regional amyloid deposition on regional cortical thickness.
    Tan CH; Chew J; Zhang L; Gulyás B; Chen C;
    Neurobiol Aging; 2022 Jul; 115():12-19. PubMed ID: 35453034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.
    Ossenkoppele R; Smith R; Ohlsson T; Strandberg O; Mattsson N; Insel PS; Palmqvist S; Hansson O
    Neurology; 2019 Feb; 92(6):e601-e612. PubMed ID: 30626656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower in vivo locus coeruleus integrity is associated with lower cortical thickness in older individuals with elevated Alzheimer's pathology: a cohort study.
    Engels-Domínguez N; Koops EA; Hsieh S; Wiklund EE; Schultz AP; Riphagen JM; Prokopiou PC; Hanseeuw BJ; Rentz DM; Sperling RA; Johnson KA; Jacobs HIL
    Alzheimers Res Ther; 2024 Jun; 16(1):129. PubMed ID: 38886798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults.
    Snitz BE; Weissfeld LA; Cohen AD; Lopez OL; Nebes RD; Aizenstein HJ; McDade E; Price JC; Mathis CA; Klunk WE
    Am J Geriatr Psychiatry; 2015 Sep; 23(9):985-93. PubMed ID: 25746485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personality Associations With Amyloid and Tau: Results From the Baltimore Longitudinal Study of Aging and Meta-analysis.
    Terracciano A; Bilgel M; Aschwanden D; Luchetti M; Stephan Y; Moghekar AR; Wong DF; Ferrucci L; Sutin AR; Resnick SM
    Biol Psychiatry; 2022 Feb; 91(4):359-369. PubMed ID: 34663503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between personality and tau-PET binding in cognitively normal older adults.
    Schultz SA; Gordon BA; Mishra S; Su Y; Morris JC; Ances BM; Duchek JM; Balota DA; Benzinger TLS
    Brain Imaging Behav; 2020 Dec; 14(6):2122-2131. PubMed ID: 31486975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.